ArticlePediatric blood & cancer2026
Real-World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital-Dispensed Model.
Article in Pediatric blood & cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blinatumomab Care Delivery for Pediatric B-Cell Acute Lymphoblastic Leukemia.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Blinatumomab has been shown to be highly effective for patients with pediatric B-ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real-world administration. In this brief report, we describe our institutional experience administering blinatumomab during the first year as standard of care therapy, including initial challenges in providing access to patients without home health coverage. We describe our process for developing and implementing a process for hospital-dispensed blinatumomab, which reduced access barriers for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.